EMA401: an old antagonist of the AT2R for a new indication in neuropathic pain

References

• McKinleyMJAlbistonALAllenAMThe brain renin-angiotensin system: location and physiological rolesInt J Biochem Cell Biol200335690191812676175
   PubMed Web of Science ®Google Scholar
• BohlenderJImbodenHAngiotensinergic neurotransmission in the peripheral autonomic nervous systemFront Biosci20121724192432
   Web of Science ®Google Scholar
• SmithMTWyseBDEdwardsSRSmall molecule angiotensin II type 2 receptor (AT2R) antagonists as novel analgesics for neuropathic pain: comparative pharmacokinetics, radioligand binding and efficacy in ratsPain Med201314569270523489258
   PubMed Web of Science ®Google Scholar
• McCarthyTSpinifex Pharmaceuticals EMA401: A Novel Treatment of Neuropathic Pain. Australasian Life Science Investment Summit1122012Melbourne, VIC, Australia
   Google Scholar
• NishimuraHRenin-angiotensin system in vertebrates: phylogenetic view of structure and functionAnat Sci Int Epub2016107
   Web of Science ®Google Scholar
• HunyadyLCattKJPleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin IIMol Endocrinol200620595397016141358
   PubMed Web of Science ®Google Scholar
• TsutsumiKSaavedraJMCharacterization and development of angiotensin II receptor subtypes (AT1 and AT2) in rat brainAm J Physiol19912611 pt 2R209R2161858948
   PubMed Web of Science ®Google Scholar
• AllenAMMoellerIJenkinsTAAngiotensin receptors in the nervous systemBrain Res Bull199847117289766385
   PubMed Web of Science ®Google Scholar
• Pelegrini-da-SilvaAMartinsARPradoWAA new role for the renin-angiotensin system in the rat periaqueductal gray matter: angiotensin receptor-mediated modulation of nociceptionNeuroscience2005132245346315802196
   PubMed Web of Science ®Google Scholar
• PorrelloERDelbridgeLMDThomasWGThe angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptorFront Biosci200914958972
   Web of Science ®Google Scholar
• WanYWallinderCPlouffeBDesign, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonistJ Med Chem200447245995600815537354
   PubMed Web of Science ®Google Scholar
• McCarthyCAVinhACallawayJKWiddopREAngiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of strokeStroke20094041482148919246705
   PubMed Web of Science ®Google Scholar
• AltermanMDevelopment of selective non-peptide angiotensin II type 2 receptor agonistsJ Renin Angiotensin Aldosterone Syst2010111576619880657
   PubMed Web of Science ®Google Scholar
• AnandUFacerPYiangouYAngiotensin II type 2 receptor (AT2 R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neuronsEur J Pain20131771012102623255326
   PubMed Web of Science ®Google Scholar
• BlankleyCJHodgesJCKlutchkoSinventorsWarner-Lambert CompanyPatent: substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties US5246943 A1992519
   Google Scholar
• SmithMTWyseBDinventorsThe University Of QueenslandPatent: method of treatment or prophylaxisWO 2006066361 A120041224
   Google Scholar
• EnglandKGPCT Written Opinion of the International Searching Authority4262006
   Google Scholar
• PappMLiXZhuangJWangRUhalBDAngiotensin receptor subtype AT(1) mediates alveolar epithelial cell apoptosis in response to ANG IIAm J Physiol Lung Cell Mol Physiol20022824L713L71811880296
   PubMed Web of Science ®Google Scholar
• MantloNBKimDOndeykaDPotent imidazo[4,5-b]- pyridine angiotensin II antagonists which exhibit balanced affinity to the AT1 and AT2 receptor subtypesBioorg Med Chem Lett199441722
   Web of Science ®Google Scholar
• SmithMTWyseBDEdwardsSRSmall molecule angiotensin II type 2 receptor (AT2R) antagonists as novel analgesics for neuropathic pain: comparative pharmacokinetics, radioligand binding, and efficacy in ratsPain Med201314569270523489258
   PubMed Web of Science ®Google Scholar
• RiceASDworkinRHMcCarthyTDEMA401-003 study group. EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trialLancet201438399291637164724507377
   PubMed Web of Science ®Google Scholar
• McCarthyTDevelopment of EMA401 as an orally-administered, highly-selective angiotensin II type 2 receptor antagonist for the treatment of neuropathic painJ Peripher Nerv Syst201419Suppl 2S13S1425269730
   PubMed Web of Science ®Google Scholar
• SmithMTAnandPRiceASSelective small molecule angiotensin II type 2 receptor antagonists for neuropathic pain: preclinical and clinical studiesPain2016157Suppl 1S33S4126785154
   PubMed Web of Science ®Google Scholar
• NovartisReimagining Medicine Available from: https://www.novartis.com/sites/www.novartis.com/files/2016-01-novartis-jpm-presentation.pdfAccessed January 27, 2016
   Google Scholar
• NovartisQ4 and Full Year 2015 Results Available from: https://www.novartis.com/sites/www.novartis.com/files/q4-2015-ir-presentation.pdfAccessed January 27, 2016
   Google Scholar